ABOUT IMP

W. Price Dunaway

Chief Operating Officer

Mr. Dunaway has twenty-five years experience in both private and public healthcare companies, coming to IMP from HealthTronics, Inc. (HTRN- NASDAQ). At HealthTronics, Mr. Dunaway was Chief Operating Officer and Senior Vice President of the Urology Services Division and also served as a member of the Board of Directors. Prior to joining HealthTronics, he specialized in fast-growth privately held healthcare companies. Prior to his tenure with HealthTronics, Mr. Dunaway was Chief Financial Officer of Osbon Medical Systems, Inc., a medical device and diagnostic equipment supplier that was sold to UroHealth. He was Chief Operating Officer of Lenox Optical, Inc., a chain of one hour superopticals that was sold to LensCrafters, Inc.

Mr. Dunaway was a regular guest lecturer at the Business School of Augusta State University, where he also served on the Board of Trustees of the Augusta State University Foundation.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IMP’s Management Team:
Deepak A. Kapoor, MD
Chairman and CEO
W. Price Dunaway
Chief Operating Officer
Carl A. Olsson, MD
Chief Medical Officer
Kathleen L. Latino, MD, FACS
Medical Director
Shawn H. Zimberg, MD
Director of Radiation Oncology Services
Ann E. Anderson, MD
Director of Pathology
Toni Rawlings, CPA
Director of Finance
Karen Hohlman
Director of Operations
Randi Pincus
Director of Marketing
Jonathan Anderson
Director of Laboratory Operations